Welcome to Mendus’ Investor Relations page. Mendus is listed on NASDAQ Stockholm under the ticker symbol IMMU. You will find all relevant information on the Mendus share in our Investors section.
The scientific committee’s work is regulated in the rules of procedure for the board of directors and an instruction adopted by the scientific committee and is evaluated annually. The chairman and one member of the scientific committee shall be board members and none of these shall be employed by the company. The board member Helén Tuvesson is chairman of the scientific committee and the board members Andrea van Elsas and Hans Preusting are a members of the scientific committee and none of aforementioned board members are employed by the company. The company’s Chief Scientific Officer and/or the managing director shall prepare the meetings in the scientific committee. The scientific committee may, if needed, obtain external advice or advice from the company’s Scientific Advisory Board. The chairman of the scientific committee shall inform the board of directors of the work of the scientific committee and shall annually evaluate the committee’s work and observance of the instructions, and submit a written evaluation to the board of directors.